Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Clinical trial NCT03921021 · COMPLETED
Trial details
- NCT number
- NCT03921021
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-09
- Primary completion
- 2023-06-20
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.